Inventor · disambiguated record
Luis Enrique Fernández Molina
Also filed as: FERNANDEZ MOLINA LUIS ENRIQUE · FERNÁNDEZ MOLINA LUIS ENRIQUE
7 granted patents·2 pending applications·28 citations·filing 1999–2023
78Inventor score
Files withCT INMUNOLOGIA MOLECULAR5CT DE IMMUNOLOGIA MOLECULAR1CT DE INMUNOLOGIA MOLECULAR CI1LANIO RUIZ MARIA ELIANA1
Top patents by PatentIndex Score
9 records- 0173US11806396B2Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccinesCT INMUNOLOGIA MOLECULAR·Filed 2018·Granted Nov 7, 2023·1 cites·18 claims
- 0269US12280109B2Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccinesCT INMUNOLOGIA MOLECULAR·Filed 2023·Granted Apr 22, 2025·0 cites·24 claims
- 0364US7776342B2Preparations that potentiate immunogenicity in low immunogenic antigensCT DE IMMUNOLOGIA MOLECULAR·Filed 2001·Granted Aug 17, 2010·8 cites·13 claims
- 0461US6429295B1Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing itCT DE INMUNOLOGIA MOLECULAR CI·Filed 1999·Granted Aug 6, 2002·19 cites·13 claims
- 0558US2024033302A1Ganglioside gm3-containing nanoparticles as immunomodulatorsCT INMUNOLOGIA MOLECULAR·Filed 2023·Application pending·0 cites
- 0654US11766462B2Ganglioside GM3-containing nanoparticles as immunomodulatorsCT INMUNOLOGIA MOLECULAR·Filed 2018·Granted Sep 26, 2023·0 cites·6 claims
- 0748US11926654B2Fusion proteins composed of an interleukin-2 mutein and type I interferonCT INMUNOLOGIA MOLECULAR·Filed 2019·Granted Mar 12, 2024·0 cites·17 claims
- 0843US2005069535A1Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosidesFiled 2002·Application pending·0 cites
- 0923US8697093B2Vaccine composition based on sticholysin encapsulated into liposomesLANIO RUIZ MARIA ELIANA·Filed 2011·Granted Apr 15, 2014·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Luis Enrique Fernández Molina files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →